Challenging Psychedelic Experiences: How Common Are “Bad Trips,” Really?

Most of what gets written about psychedelics these days is about benefit — the studies on depression, the shifts people report, the growing clinical legitimacy of medicines that were taboo a decade ago.

That conversation is real, and I'm part of it. But there's another question that doesn't get asked as often, and I think it deserves a clearer answer:

How often do people have difficult or distressing psychedelic experiences? And what makes them more likely?

If you're considering psychedelic therapy yourself, or if you're sitting with a hard experience you've already had, this is worth knowing. A 2023 study in the Journal of Affective Disorders by Simonsson and colleagues offers some of the clearest data we have so far. (You can read the abstract here.)

I want to walk through what they found — and what it means in practice.

Why Real-World Data Matters

Most of what we know about psychedelic safety comes from clinical trials. In those settings, participants are carefully screened, prepared, supported, and held in well-designed environments. The results in those conditions tend to be favorable.

But most people who use psychedelics aren't in clinical trials. They're in living rooms, festivals, ceremony spaces, retreats, telehealth ketamine programs, and a wide range of contexts where preparation, support, and screening vary enormously.

This study tried to look at what's actually happening outside the clinic — across nearly 3,000 U.S. adults, with 613 of them reporting they'd used classic psychedelics like LSD, psilocybin, DMT, or mescaline at some point in their lives.

That makes it one of the more honest looks at psychedelic experiences as people actually have them.

How Common Are Difficult Experiences?

The headline finding is more nuanced than either side of the conversation usually acknowledges.

Most people — 59.1% — said they had never had a challenging or distressing psychedelic experience.

That's worth saying clearly. The dominant story isn't catastrophe.

But about 41% reported at least occasional difficulty. Around 8.9% experienced impairment lasting longer than a day. Roughly 4.6% reported severe functional impairment afterward.

So serious issues aren't the norm. But they're not rare either. If you're choosing to do this work, the chance of running into something difficult isn't trivial — and the question becomes how to make the difficult less likely, and how to be prepared if it happens anyway.

What Lingers After a Hard Experience

For people who did have a difficult experience, the after-effects often included things that lasted several days or more:

Anxiety. Sleep disruption. Difficulty thinking clearly. A sense of being disconnected from other people, or from reality itself.

These aren't psychedelic "side effects" the way we usually think about side effects. They're often signs that something significant was stirred up and not adequately metabolized — which is, in my view, a strong argument for proper integration support after any meaningful experience, not just the ones that go beautifully.

Here's the part that surprised me, though, and that mirrors what I see clinically:

Most participants who had difficult experiences still said they were glad they'd used psychedelics overall.

This is one of the most interesting patterns in psychedelic research. Hard experiences often turn out, in retrospect, to be meaningful — sometimes even more meaningful than the ones that felt purely good. The ancient teaching that the most difficult moments often hold the deepest medicine seems to bear out in real-world data.

But — and this is important — that retrospective meaning depends almost entirely on what happens after. Without integration, a hard experience can stay hard. With integration, the same experience can become some of the most important psychological work a person ever does.

The Risks Worth Naming Clearly

A smaller but significant percentage of participants reported more serious outcomes:

About 6.7% reported thoughts of harming themselves or others, or attempts at it, after a difficult experience.

About 2.6% sought medical, psychiatric, or psychological help.

These are not majority outcomes. But they're real, and they're a reminder that psychedelics are not benign. They're powerful psychoactive substances, and they deserve to be treated as such — by people considering them, and by the providers offering them.

What Actually Predicts a Hard Experience

This is the part of the study I find most useful, because it points toward what we can actually do.

The factors that most consistently predicted difficult experiences:

No preparation beforehand. Going in without having done any psychological work to ready yourself.

A negative mindset going in. Approaching the experience while feeling depressed, anxious, scared, or in active emotional crisis.

Lack of psychological support. Being alone, or with people who aren't equipped to help if things get hard.

A disagreeable physical environment. Settings that don't feel safe, comfortable, or appropriate to the work.

Taking too high a dose. Particularly without titration or guidance.

A major life stressor in the recent past. Going into a session while still raw from something else.

If this list looks familiar, it's because it's essentially the inverse of what good clinical psychedelic work tries to provide. Preparation. Mindset work. Support. Containment. Appropriate dosing. Choosing the right time.

The research is essentially saying: when those things are in place, the chance of a hard experience drops significantly. When they're missing, it rises.

This is one of the reasons I take preparation as seriously as the medicine session itself in my own KAP practice — not because I'm being overly cautious, but because the data on what protects people is clear.

Medication Interactions

The study also found higher risk of difficult experiences when participants were taking certain medications — particularly lithium and other mood stabilizers. These combinations were associated with more intense challenging experiences and a greater risk of harm.

This isn't surprising — it's part of why responsible KAP and psychedelic therapy programs do thorough medication screening. But it underscores why telehealth ketamine platforms that minimize screening are taking on real risk that often falls on the patient.

If you're considering any psychedelic therapy, your medication list matters. A provider who isn't asking detailed questions about every medication you take — including supplements and PRN meds — isn't doing the basic work of keeping you safe.

What People Actually Did to Move Through Difficulty

For the participants who had difficult moments and worked through them, the strategies that helped were largely simple

Trying to calm the mind. Changing physical location. Asking a trusted friend for support. Shifting the social environment.

The study suggests that calming practices — mindfulness, grounding, breathing techniques — were particularly useful for navigating hard moments in real time.

This is part of why I include nervous-system regulation skills in preparation work. You don't want to be learning to breathe through difficulty for the first time during a session. You want those tools already in your body, available, before the medicine ever opens anything.

What This Means for You

If you're someone considering psychedelic therapy, here's what I'd take from this research:

Most people don't have catastrophic experiences. The doom narrative is overblown.

Difficult experiences are common enough to take seriously. About 4 in 10 users encounter at least some difficulty.

What you do before, around, and after the experience matters enormously. Preparation, environment, support, and integration aren't bonus features. They're the things that most reliably distinguish a meaningful experience from a destabilizing one.

If you're already on certain medications — particularly mood stabilizers — your provider needs to know, and you need a thorough screening. Anyone offering psychedelic treatment without that screening is cutting a corner you don't want cut on you.

A hard experience isn't the end of the road. With proper integration, even challenging experiences can become some of the most important psychological work of your life.

A Last Thought

Psychedelics are neither inherently safe nor inherently dangerous. They are powerful — and like anything powerful, they reward care and punish carelessness.

The research keeps pointing at the same conclusion: context matters more than substance. Mindset, environment, preparation, and support aren't secondary details. They may be the entire difference between an experience that transforms someone and one that destabilizes them.

If you're considering KAP or you're working through a difficult experience you've already had, I'd be glad to talk with you. Whether the experience went smoothly or didn't, real integration support changes what becomes possible afterward. You can book a free consultation here.